Literature DB >> 17686380

Spironolactone use in resistant hypertension.

Dan Carl1, Domenic A Sica.   

Abstract

Entities:  

Year:  2007        PMID： 17686380     DOI： 10.1007/s11906-007-0054-y

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  6 in total

1.  Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

Authors:  William C Cushman; Charles E Ford; Jeffrey A Cutler; Karen L Margolis; Barry R Davis; Richard H Grimm; Henry R Black; Bruce P Hamilton; Joanne Holland; Chuke Nwachuku; Vasilios Papademetriou; Jeffery Probstfield; Jackson T Wright; Michael H Alderman; Robert J Weiss; Linda Piller; Judy Bettencourt; Sandra M Walsh
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

Review 2.  Use of aldosterone antagonists in resistant hypertension.

Authors:  David A Calhoun
Journal:  Prog Cardiovasc Dis       Date:  2006 May-Jun       Impact factor: 8.194

3.  Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension.

Authors:  Yehonatan Sharabi; Eldad Adler; Ari Shamis; Naomi Nussinovitch; Avinoam Markovitz; Ehud Grossman
Journal:  Am J Hypertens       Date:  2006-07       Impact factor: 2.689

4.  The role of spironolactone in the treatment of patients with refractory hypertension.

Authors:  James Ouzan; Catherine Pérault; A Michael Lincoff; Evelyne Carré; Michel Mertes
Journal:  Am J Hypertens       Date:  2002-04       Impact factor: 2.689

5.  Efficacy of low-dose spironolactone in subjects with resistant hypertension.

Authors:  Mari Konishi Nishizaka; Mohammad Amin Zaman; David A Calhoun
Journal:  Am J Hypertens       Date:  2003-11       Impact factor: 2.689

6.  Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991.

Authors:  V L Burt; J A Cutler; M Higgins; M J Horan; D Labarthe; P Whelton; C Brown; E J Roccella
Journal:  Hypertension       Date:  1995-07       Impact factor: 10.190
  6 in total
  1 in total

1.  Resistant hypertension optimal treatment trial: a randomized controlled trial.

Authors:  Eduardo M Krieger; Luciano F Drager; Dante Marcelo Artigas Giorgi; Jose Eduardo Krieger; Alexandre Costa Pereira; José Augusto Soares Barreto-Filho; Armando da Rocha Nogueira; José Geraldo Mill
Journal:  Clin Cardiol       Date:  2013-12-11       Impact factor: 2.882
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.